Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71-85% effective.
This report contains market size and forecasts of Pertussis Vaccine in US, including the following market information:
US Pertussis Vaccine Market Revenue, 2015-2020, 2021-2026, ($ millions)
US Pertussis Vaccine Market Consumption, 2015-2020, 2021-2026, (K Doses)
US Pertussis Vaccine Production Capacity, 2015-2020, 2021-2026, (K Doses)
Top Five Competitors in US Pertussis Vaccine Market 2019 (%)
The global Pertussis Vaccine market was valued at 7342.7 million in 2019 and is projected to reach US$ 7535.7 million by 2026, at a CAGR of 0.7% during the forecast period. While the Pertussis Vaccine market size in US was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pertussis Vaccine manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Pertussis Vaccine production and consumption in US
Total Market by Segment:
US Pertussis Vaccine Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Doses)
US Pertussis Vaccine Market Segment Percentages, By Type, 2019 (%)
- Whole-cell vaccines
- Acellular vaccines
US Pertussis Vaccine Market, By Application, 2015-2020, 2021-2026 ($ millions) & (K Doses)
US Pertussis Vaccine Market Segment Percentages, By Application, 2019 (%)
- Children
- Adults
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Pertussis Vaccine Market Competitors Revenues in US, by Players 2015-2020 (Estimated), ($ millions)
Total Pertussis Vaccine Market Competitors Revenues Share in US, by Players 2019 (%)
Total US Pertussis Vaccine Market Competitors Sales, by Players 2015-2020 (Estimated), (K Doses)
Total US Pertussis Vaccine Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
- Sanofi Pasteur
- GSK
- Mitsubishi Tanabe Pharma
- Astellas Pharma
- Minhai Biotechnology
- Wuhan Institute of Biological Products
Pertussis Vaccine Market in US - Manufacturing and Consumption, Outlook and Forecast 2020-2026
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Pertussis Vaccine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 US Pertussis Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 COVID-19 Impact: US Pertussis Vaccine Overall Market Size
2.1 US Pertussis Vaccine Market Size: 2020 VS 2026
2.2 US Pertussis Vaccine Revenue, Prospects & Forecasts: 2015-2026
2.3 US Pertussis Vaccine Sales (Consumption): 2015-2026
3 Company Landscape
3.1 Top Pertussis Vaccine Players in US (including Foreign and Local Companies)
3.2 Top US Pertussis Vaccine Companies Ranked by Revenue
3.3 US Pertussis Vaccine Revenue by Companies (including Foreign and Local Companies)
3.4 US Pertussis Vaccine Sales by Companies (including Foreign and Local Companies)
3.5 US Pertussis Vaccine Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Pertussis Vaccine Companies in US, by Revenue in 2019
3.7 US Manufacturers Pertussis Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pertussis Vaccine Players in US
3.8.1 List of US Tier 1 Pertussis Vaccine Companies
3.8.2 List of US Tier 2 and Tier 3 Pertussis Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - US Pertussis Vaccine Market Size Markets, 2020 & 2026
4.1.2 Whole-cell vaccines
4.1.3 Acellular vaccines
4.2 By Type - US Pertussis Vaccine Revenue & Forecasts
4.2.1 By Type - US Pertussis Vaccine Revenue, 2015-2020
4.2.2 By Type - US Pertussis Vaccine Revenue, 2021-2026
4.2.3 By Type - US Pertussis Vaccine Revenue Market Share, 2015-2026
4.3 By Type - US Pertussis Vaccine Sales & Forecasts
4.3.1 By Type - US Pertussis Vaccine Sales, 2015-2020
4.3.2 By Type - US Pertussis Vaccine Sales, 2021-2026
4.3.3 By Type - US Pertussis Vaccine Sales Market Share, 2015-2026
4.4 By Type - US Pertussis Vaccine Price (Manufacturers Selling Prices), 2015-2026
5 Sights by Application
5.1 Overview
5.1.1 By Application - US Pertussis Vaccine Market Size, 2020 & 2026
5.1.2 Children
5.1.3 Adults
5.2 By Application - US Pertussis Vaccine Revenue & Forecasts
5.2.1 By Application - US Pertussis Vaccine Revenue, 2015-2020
5.2.2 By Application - US Pertussis Vaccine Revenue, 2021-2026
5.2.3 By Application - US Pertussis Vaccine Revenue Market Share, 2015-2026
5.3 By Application - US Pertussis Vaccine Sales & Forecasts
5.3.1 By Application - US Pertussis Vaccine Sales, 2015-2020
5.3.2 By Application - US Pertussis Vaccine Sales, 2021-2026
5.3.3 By Application - US Pertussis Vaccine Sales Market Share, 2015-2026
5.4 By Application - US Pertussis Vaccine Price (Manufacturers Selling Prices), 2015-2026
6 Manufacturers & Brands Profiles
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Corporate Summary
6.1.2 Sanofi Pasteur Business Overview
6.1.3 Sanofi Pasteur Pertussis Vaccine Major Product Offerings
6.1.4 Sanofi Pasteur Sales and Revenue in US (2015-2020)
6.1.5 Sanofi Pasteur Key News
6.2 GSK
6.2.1 GSK Corporate Summary
6.2.2 GSK Business Overview
6.2.3 GSK Pertussis Vaccine Major Product Offerings
6.2.4 GSK Sales and Revenue in US (2015-2020)
6.2.5 GSK Key News
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Corporate Summary
6.3.2 Mitsubishi Tanabe Pharma Business Overview
6.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Major Product Offerings
6.3.4 Mitsubishi Tanabe Pharma Sales and Revenue in US (2015-2020)
6.3.5 Mitsubishi Tanabe Pharma Key News
6.4 Astellas Pharma
6.4.1 Astellas Pharma Corporate Summary
6.4.2 Astellas Pharma Business Overview
6.4.3 Astellas Pharma Pertussis Vaccine Major Product Offerings
6.4.4 Astellas Pharma Sales and Revenue in US (2015-2020)
6.4.5 Astellas Pharma Key News
6.5 Minhai Biotechnology
6.5.1 Minhai Biotechnology Corporate Summary
6.5.2 Minhai Biotechnology Business Overview
6.5.3 Minhai Biotechnology Pertussis Vaccine Major Product Offerings
6.5.4 Minhai Biotechnology Sales and Revenue in US (2015-2020)
6.5.5 Minhai Biotechnology Key News
6.6 Wuhan Institute of Biological Products
6.6.1 Wuhan Institute of Biological Products Corporate Summary
6.6.2 Wuhan Institute of Biological Products Business Overview
6.6.3 Wuhan Institute of Biological Products Pertussis Vaccine Major Product Offerings
6.6.4 Wuhan Institute of Biological Products Sales and Revenue in US (2015-2020)
6.6.5 Wuhan Institute of Biological Products Key News
6.7 Changchun Changsheng Life Sciences
6.6.1 Changchun Changsheng Life Sciences Corporate Summary
6.6.2 Changchun Changsheng Life Sciences Business Overview
6.6.3 Changchun Changsheng Life Sciences Pertussis Vaccine Major Product Offerings
6.4.4 Changchun Changsheng Life Sciences Sales and Revenue in US (2015-2020)
6.7.5 Changchun Changsheng Life Sciences Key News
7 Pertussis Vaccine Production Capacity, Export and Import Analysis
7.1 Pertussis Vaccine Production Capacity and Value in US, Situation Analysis and Prediction, 2015-2026
7.1.1 US Pertussis Vaccine Production Capacity, 2015-2026
7.1.2 US Pertussis Vaccine Production 2015-2026
7.1.3 US Pertussis Vaccine Production Value 2015-2026
7.2 Key Local Pertussis Vaccine Manufacturers in US
7.2.1 US Key Local Pertussis Vaccine Manufacturers Production Capacity
7.2.2 US Key Local Pertussis Vaccine Manufacturers Production
7.2.3 US Key Local Pertussis Vaccine Manufacturers Production Value
7.2.4 The Proportion of Pertussis Vaccine Production Sold in US and Sold Other Than US by Manufacturers
7.3 Pertussis Vaccine Export and Import in US
7.3.1 US Pertussis Vaccine Export Market
7.3.2 US Pertussis Vaccine Source of Imports
8 COVID-19 Impact: Key Market Trends, Opportunity, Drivers and Restraints
8.1 PESTLE Analysis for US Pertussis Vaccine Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints
9 COVID-19 Impact on Pertussis Vaccine Supply Chain Analysis
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Pertussis Vaccine Distributors and Sales Agents in US
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
List of Tables
Table 1. Key Players of Pertussis Vaccine in US
Table 2. Top Players in US, Ranking by Revenue (2019)
Table 3. US Pertussis Vaccine Revenue by Companies, (US$, Mn), 2015-2020
Table 4. US Pertussis Vaccine Revenue Share by Companies, 2015-2020
Table 5. US Pertussis Vaccine Sales by Companies, (K Doses), 2015-2020
Table 6. US Pertussis Vaccine Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Pertussis Vaccine Price (2015-2020) (USD/Doses)
Table 8. US Manufacturers Pertussis Vaccine Product Type
Table 9. List of US Tier 1 Pertussis Vaccine Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of US Tier 2 and Tier 3 Pertussis Vaccine Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Pertussis Vaccine Revenue in US (US$, Mn), 2015-2020
Table 12. By Type - Pertussis Vaccine Revenue in US (US$, Mn), 2021-2026
Table 13. By Type - Pertussis Vaccine Sales in US (K Doses), 2015-2020
Table 14. By Type - Pertussis Vaccine Sales in US (K Doses), 2021-2026
Table 15. By Application - Pertussis Vaccine Revenue in US, (US$, Mn), 2015-2020
Table 16. By Application - Pertussis Vaccine Revenue in US, (US$, Mn), 2021-2026
Table 17. By Application - Pertussis Vaccine Sales in US, (K Doses), 2015-2020
Table 18. By Application - Pertussis Vaccine Sales in US, (K Doses), 2021-2026
Table 19. Sanofi Pasteur Corporate Summary
Table 20. Sanofi Pasteur Pertussis Vaccine Product Offerings
Table 21. Sanofi Pasteur Pertussis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2015-2020)
Table 22. GSK Corporate Summary
Table 23. GSK Pertussis Vaccine Product Offerings
Table 24. GSK Pertussis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2015-2020)
Table 25. Mitsubishi Tanabe Pharma Corporate Summary
Table 26. Mitsubishi Tanabe Pharma Pertussis Vaccine Product Offerings
Table 27. Mitsubishi Tanabe Pharma Pertussis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2015-2020)
Table 28. Astellas Pharma Corporate Summary
Table 29. Astellas Pharma Pertussis Vaccine Product Offerings
Table 30. Astellas Pharma Pertussis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2015-2020)
Table 31. Minhai Biotechnology Corporate Summary
Table 32. Minhai Biotechnology Pertussis Vaccine Product Offerings
Table 33. Minhai Biotechnology Pertussis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2015-2020)
Table 34. Wuhan Institute of Biological Products Corporate Summary
Table 35. Wuhan Institute of Biological Products Pertussis Vaccine Product Offerings
Table 36. Wuhan Institute of Biological Products Pertussis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2015-2020)
Table 37. Changchun Changsheng Life Sciences Corporate Summary
Table 38. Changchun Changsheng Life Sciences Pertussis Vaccine Product Offerings
Table 39. Changchun Changsheng Life Sciences Pertussis Vaccine Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Doses) (2015-2020)
Table 40. Pertussis Vaccine Production Capacity (K Doses) of Local Manufacturers in US, 2015-2020
Table 41. Pertussis Vaccine Production (K Doses) of Local Manufacturers in US, 2015-2020
Table 42. US Pertussis Vaccine Production Market Share of Local Manufacturers, 2015-2020
Table 43. Pertussis Vaccine Production Value (US$, Mn) of Local Manufacturers in US, 2015-2020
Table 44. US Pertussis Vaccine Production Value Market Share of Local Manufacturers, 2015-2020
Table 45. The Percentage of Pertussis Vaccine Production Sold in US and Sold Other Than US by Manufacturers
Table 46. The Percentage of Pertussis Vaccine Production Sold in US and Sold Other Than US by Manufacturers
Table 47. Dangeguojia Pertussis Vaccine Sales (Consumption), Production, Export and Import, 2015-2020
Table 48. Raw Materials and Suppliers
Table 49. Pertussis Vaccine Downstream Clients in US
Table 50. Pertussis Vaccine Distributors and Sales Agents in US
List of Figures
Figure 1. Pertussis Vaccine Segment by Type
Figure 2. Pertussis Vaccine Segment by Application
Figure 3. Dangeguojia Pertussis Vaccine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Pertussis Vaccine Market Size in US, (US$, Mn) & (K Doses): 2020 VS 2026
Figure 6. US Pertussis Vaccine Revenue, 2015-2026 (US$, Mn)
Figure 7. Pertussis Vaccine Sales in US: 2015-2026 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Pertussis Vaccine Revenue in 2019
Figure 9. By Type - US Pertussis Vaccine Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - US Pertussis Vaccine Market Share, 2015-2020
Figure 11. By Type - US Pertussis Vaccine Market Share, 2020-2026
Figure 12. By Type - US Pertussis Vaccine Price (USD/Doses), 2015-2026
Figure 13. By Application - Pertussis Vaccine Revenue in US (US$, Mn), 2020 & 2026
Figure 14. By Application - US Pertussis Vaccine Market Share, 2015-2020
Figure 15. By Application - US Pertussis Vaccine Market Share, 2020-2026
Figure 16. By Application -US Pertussis Vaccine Price (USD/Doses), 2015-2026
Figure 17. US Pertussis Vaccine Production Capacity (K Doses), 2015-2026
Figure 18. US Pertussis Vaccine Actual Output (K Doses), 2015-2026
Figure 19. US Pertussis Vaccine Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of US Pertussis Vaccine Export Destination, 2019
Figure 21. The Source of Imports of US Pertussis Vaccine, 2019
Figure 22. PEST Analysis for US Pertussis Vaccine Market in 2020
Figure 23. Pertussis Vaccine Market Opportunities & Trends in US
Figure 24. Pertussis Vaccine Market Drivers in US
Figure 25. Pertussis Vaccine Market Restraints in US
Figure 26. Pertussis Vaccine Industry Value Chain
Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 87
The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
Global Esomeprazole Magnesium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 74
The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030.
North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
Global Combination Therapy Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
Global Axitinib Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 68
The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
Global Lyme Disease Vaccine Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 70
The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi.
The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at......
Global Transdermal Absorption Patch Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
Global Ketoprofen Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis
The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
Global Methyl Salicylate Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 82
The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
Global Diclofenac Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
